Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors.

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 4, 2021

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions

Advanced Solid Tumors

Interventions

DRUG

Paclitaxel Micelles for Injection

Paclitaxel Micelles for Injection was intravenously administrated for three hours, three weeks constituted one course of treatment.

DRUG

Paclitaxel injection

Paclitaxel Injection was intravenously administrated for three hours, three weeks constituted one course of treatment.

Trial Locations (1)

RECRUITING

The First Affiliated Hospital,ZheJiang Univercity, Hanzhou

All Listed Sponsors

collaborator

Hangzhou Dihua Biotechnology Co., LTD.

UNKNOWN

lead

First Affiliated Hospital of Zhejiang University

OTHER

NCT04778839 - Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors. | Biotech Hunter | Biotech Hunter